Kiniksa Pharmaceuticals Ltd (KNSA)
19.99
-0.09
(-0.45%)
USD |
NASDAQ |
May 06, 16:00
20.00
+0.01
(+0.05%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Free Cash Flow (Quarterly): 3.903M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.903M |
| December 31, 2023 | 4.269M |
| September 30, 2023 | 16.97M |
| June 30, 2023 | -3.777M |
| March 31, 2023 | -4.291M |
| December 31, 2022 | -11.54M |
| September 30, 2022 | 62.03M |
| June 30, 2022 | -7.939M |
| March 31, 2022 | -36.85M |
| December 31, 2021 | -19.14M |
| September 30, 2021 | -28.56M |
| June 30, 2021 | -38.84M |
| March 31, 2021 | -60.18M |
| December 31, 2020 | -41.25M |
| September 30, 2020 | -34.33M |
| Date | Value |
|---|---|
| June 30, 2020 | -29.22M |
| March 31, 2020 | -32.02M |
| December 31, 2019 | -26.17M |
| September 30, 2019 | -29.71M |
| June 30, 2019 | -40.88M |
| March 31, 2019 | -64.82M |
| December 31, 2018 | -31.65M |
| September 30, 2018 | -21.45M |
| June 30, 2018 | -18.15M |
| March 31, 2018 | -15.05M |
| December 31, 2017 | -23.38M |
| September 30, 2017 | -10.97M |
| June 30, 2017 | -10.24M |
| March 31, 2017 | -5.697M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-60.18M
Minimum
Mar 2021
62.03M
Maximum
Sep 2022
-17.88M
Average
-27.36M
Median
Free Cash Flow (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 1.727M |
| Geron Corp | -62.87M |
| United Therapeutics Corp | 338.30M |
| Vanda Pharmaceuticals Inc | -3.985M |
| TG Therapeutics Inc | -13.21M |